In March, we added 122 citations in DIDB, including 58 in vitro (with 14 articles published in April 2026) and 64 in vivo articles (with 25 articles published in April 2026).
2 drugs approved by the FDA in March 2026, including relacorilant (LIFYORLI) and tividenofusp alfa (AVLAYAH), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.